SMAD4 and pancreatic neoplasm: In turn, the gene encoding the tumor suppressor protein SMAD4 is inactivated in 50–55% of pancreatic cancers, and the role of its loss in PC remains controversial but appears to be associated with poorer overall survival and metastasis.